Novoheart (CVE:NVH) Reaches New 1-Year Low at $0.23
Novoheart Holdings Inc (CVE:NVH)’s share price reached a new 52-week low on Tuesday . The stock traded as low as C$0.23 and last traded at C$0.23, with a volume of 83258 shares traded. The stock had previously closed at C$0.25.
The stock has a market capitalization of $46.14 million and a PE ratio of -2.67. The company has a fifty day simple moving average of C$0.26.
About Novoheart (CVE:NVH)
Novoheart Holdings Inc operates as a stem cell biotechnology company in the United States, Canada, and Hong Kong. It offers an array of next-generation human heart tissue prototypes. The company provides a range of bioengineering technologies known as the MyHeart platform, including the human mini-heart ‘novoHeart' that is capable of pumping and ejecting fluid.
Featured Story: How prevalent are 12b-1 fees?
Receive News & Ratings for Novoheart Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novoheart and related companies with MarketBeat.com's FREE daily email newsletter.